These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 13698407)

  • 1. [Effect of a lipopolysaccharide extract of salmonella abortus equi on the radiological course of cavernous tuberculosis resistant to antibiotics].
    FAVEZ G; TATTI V
    Rev Bras Tuberc Doencas Torac; 1960; 28():351-3. PubMed ID: 13698407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Noxious corticotherapy during the course of pulmonary tuberculosis with bacteria resistant to antibiotics].
    BRUN J; VALLIER J
    Sem Hop; 1957 Dec; 33(69):4063-8. PubMed ID: 13519131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of inunction of mercury on the course of therapy of pleural empyema and of sero-cavernous pulmonary tuberculosis with special reference to bioptic picture of the bone marrow].
    RETINGER M
    Przegl Lek; 1953; 9(9):22-5. PubMed ID: 13134373
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution to the study of the biological effects of a lipopolysaccharide of bacterial origin in pulmonary tuberculosis].
    TATTI V
    Schweiz Z Tuberc Pneumonol; 1960; 17():1-61. PubMed ID: 13837050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Materials for discovery of drug-resistant Mycobacterium tuberculosis in sputum in patients with chronic fibro-cavernous processes in the lungs].
    ASEEV DD
    Probl Tuberk; 1958; 36(4):14-20. PubMed ID: 13601637
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological effects of a highly purified pyrogen (lipopolysaccharide) from Salmonella abortus equi].
    EICHENBERGER E; SCHMIDHAUSER-KOPP M; HURNI H; FRICSAY M; WESTPHAL O
    Schweiz Med Wochenschr; 1955 Dec; 85(49):1190-6; contd. PubMed ID: 13298644
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactive nitrogen intermediate production and tolerance variability in different mouse strains after in vivo treatment with lipopolysaccharide from Salmonella abortus equi.
    Nahrevanian H; Salmasi JG; Farahmand M; Aghighi Z; Assmar M; Abolhassani M
    J Microbiol Immunol Infect; 2005 Jun; 38(3):164-8. PubMed ID: 15986065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
    Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
    Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of pyrogens (lipopolysaccharides) from Salmonella abortus equi on the osmotic & mechanical resistance of white blood cells in normal persons].
    BELLESIA L; LUSVARGHI E; MUCCI P
    Schweiz Med Wochenschr; 1958 Sep; 88(38):929-30. PubMed ID: 13592199
    [No Abstract]   [Full Text] [Related]  

  • 10. Postural dependency treatment in cavernous pulmonary tuberculosis.
    HENSCHEL EO
    Can Med Assoc J; 1957 Sep; 77(5):469-77. PubMed ID: 13460868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of cavernous pulmonary tuberculosis with antibacterial preparations; preliminary report].
    NACHEV V
    Suvr Med (Sofiia); 1958; 9(9):71-6. PubMed ID: 13615663
    [No Abstract]   [Full Text] [Related]  

  • 12. [Causes of failure and outcome of prolonged antibacterial therapy of cavernous pulmonary tuberculosis].
    KLEBANOV MA; KHVUL' RM; ABERMAN AA; KSHANOVSKII SA; PRZHEVAL'SKAIA LA
    Probl Tuberk; 1958; 36(6):16-28. PubMed ID: 13601690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Further experiences with hinokitiol therapy in large cavernous, chemotherapeutic resistent pulmonary tuberculosis].
    KATSURA S; FURUDERA H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 116(6):463-8. PubMed ID: 13426008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of antibacterial preparations on the course and complications of pulmonary tuberculosis].
    LIFSHITS NA
    Sov Med; 1958 Aug; 22(8):114-9. PubMed ID: 13615467
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the segmental location of the cavern on the course and outcome of pulmonary tuberculosis].
    Popova II
    Vrach Delo; 1971 Oct; 10():79-82. PubMed ID: 5142542
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the types of chemotherapy in pulmonary tuberculosis. 3. Chemotherapy of patients with far advanced pulmonary tuberculosis and resistant tubercle bacilli].
    YOSHIDA F; SHIOZUKA S; HIRASHIMA N; MURATA S; NISHIYAMA K; SHIMOSAKA S
    Kekkaku; 1962 Feb; 37():80-4. PubMed ID: 14009212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin combined with antibiotics in the therapy of lymph node tuberculosis, cold abscesses and pulmonary tuberculosis].
    WEIL JA
    Rev Tuberc Pneumol (Paris); 1961; 25():1092-102. PubMed ID: 14005652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapeutic efficacy of BCG vaccine in pulmonary tuberculosis and its preventive effect on multidrug-resistant tuberculosis].
    Lei JP; Xiong GL; Hu QF; Li Y; Zong PL; Tu SH; Tu RY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Feb; 42(2):86-9. PubMed ID: 18642658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiological follow-up studies for 4 years of ambulatory chemotherapy in pulmonary tuberculosis].
    HONDO G; YAMAGUCHI T; SEKURA T
    Kekkaku; 1960 Oct; 35():696-9. PubMed ID: 13715650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of antibiotics in the treatment of pulmonary tuberculosis].
    MORNAND P; ROSSIGNOL J
    Concours Med; 1957 Aug; 79(35):3831-4. PubMed ID: 13461471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.